$1.20
-0.07-5.51%
At Close: -
$1.18
-0.02-1.53%
After Hours: 6:29 PM EDT
15 minutes delayed
Comments
Loading...
Bio-Path Hldgs (BPTH) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBio-Path Hldgs (NASDAQ:BPTH) Stock Quotes, Forecast and News Summary
Bio-Path Hldgs Stock (NASDAQ: BPTH) stock price, news, charts, stock research, profile.
| Open | $1.23 |
| Close | $1.20 |
| Volume / Avg. | 604.54K / 1.34M |
| Day Range | $1.10 - $1.24 |
| 52 Wk Range | 1.20 - 21.60 |
| Market Cap | $3.02M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 29 |
| Short Interest | 2.4% |
| Days to Cover | 1.19 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Bio-Path Holdings Inc
Sector
Health Care
Industry
Biotechnology
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug de...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Bio-Path Hldgs (BPTH) stock?
You can purchase shares of Bio-Path Hldgs (NASDAQ:BPTH) through any online brokerage.
Who are Bio-Path Hldgs (BPTH) competitors?
Other companies in Bio-Path Hldgs’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
What is the forecast, or price target, for Bio-Path Hldgs (BPTH) stock?
Bio-Path Hldgs has a consensus price target of $23.00.
What is the current price for Bio-Path Hldgs (BPTH)?
The stock price for Bio-Path Hldgs (NASDAQ: BPTH) is $1.1816 last updated August 23, 2024 at 6:29 PM EDT.
Does Bio-Path Hldgs (BPTH) pay a dividend?
There are no upcoming dividends for Bio-Path Hldgs.
When is Bio-Path Hldgs (NASDAQ:BPTH) reporting earnings?
Bio-Path Hldgs’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
Is Bio-Path Hldgs (BPTH) going to split?
There is no upcoming split for Bio-Path Hldgs.
What sector and industry does Bio-Path Hldgs (BPTH) operate in?
Bio-Path Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.